138 related articles for article (PubMed ID: 32267166)
1. Clinical role of MiRNA 29a and MiRNA 335 on breast cancer management: their relevance to MMP2 protein level.
Ali Ahmed E; Abd El-Basit SA; Mohamed MA; Swellam M
Arch Physiol Biochem; 2022 Aug; 128(4):1058-1065. PubMed ID: 32267166
[TBL] [Abstract][Full Text] [Related]
2. Expression of MiR-335 and its target metalloproteinase genes: clinical significance in breast cancer.
Ramadan A; Hashim M; M Hassan N; Swellam M
Arch Physiol Biochem; 2022 Jun; 128(3):569-575. PubMed ID: 31922434
[TBL] [Abstract][Full Text] [Related]
3. Decreased serum miR-181a is a potential new tool for breast cancer screening.
Guo LJ; Zhang QY
Int J Mol Med; 2012 Sep; 30(3):680-6. PubMed ID: 22692639
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of blood-based miRNAs as diagnostic and prognostic nucleic acid markers in breast cancer: Comparative to conventional tumor markers.
Swellam M; Ramadan A; El-Hussieny EA; Bakr NM; Hassan NM; Sobeih ME; EzzElArab LR
J Cell Biochem; 2019 Aug; 120(8):12321-12330. PubMed ID: 30825229
[TBL] [Abstract][Full Text] [Related]
5. Serum microRNA-195 is down-regulated in breast cancer: a potential marker for the diagnosis of breast cancer.
Zhao FL; Dou YC; Wang XF; Han DC; Lv ZG; Ge SL; Zhang YK
Mol Biol Rep; 2014 Sep; 41(9):5913-22. PubMed ID: 25103018
[TBL] [Abstract][Full Text] [Related]
6. The Clinical Significance of sICAM-1 in Differentiating Benign Breast Lesions from Breast Cancer.
Chen C; Chen Q; Dong Y; Liu X
Ann Clin Lab Sci; 2020 Sep; 50(5):650-656. PubMed ID: 33067211
[TBL] [Abstract][Full Text] [Related]
7. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.
Brunet Vega A; Pericay C; Moya I; Ferrer A; Dotor E; Pisa A; Casalots À; Serra-Aracil X; Oliva JC; Ruiz A; Saigí E
Oncol Rep; 2013 Jul; 30(1):320-6. PubMed ID: 23673725
[TBL] [Abstract][Full Text] [Related]
8. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
Kodahl AR; Lyng MB; Binder H; Cold S; Gravgaard K; Knoop AS; Ditzel HJ
Mol Oncol; 2014 Jul; 8(5):874-83. PubMed ID: 24694649
[TBL] [Abstract][Full Text] [Related]
9. Role of some circulating MiRNAs on breast cancer diagnosis.
Swellam M; Zahran RFK; Abo El-Sadat Taha H; El-Khazragy N; Abdel-Malak C
Arch Physiol Biochem; 2019 Dec; 125(5):456-464. PubMed ID: 29925280
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of miR-106b induced breast cancer cell invasion and motility in association with overexpression of matrix metalloproteinase 2.
Ni X; Xia T; Zhao Y; Zhou W; Wu N; Liu X; Ding Q; Zha X; Sha J; Wang S
Cancer Sci; 2014 Jan; 105(1):18-25. PubMed ID: 24164962
[TBL] [Abstract][Full Text] [Related]
11. Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia.
Yamada A; Horimatsu T; Okugawa Y; Nishida N; Honjo H; Ida H; Kou T; Kusaka T; Sasaki Y; Yagi M; Higurashi T; Yukawa N; Amanuma Y; Kikuchi O; Muto M; Ueno Y; Nakajima A; Chiba T; Boland CR; Goel A
Clin Cancer Res; 2015 Sep; 21(18):4234-42. PubMed ID: 26038573
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic significance of circulating miRNAs and metabolite profiling in early prediction of breast cancer in Egyptian women.
El-Toukhy SE; El-Daly SM; Kamel MM; Nabih HK
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5437-5451. PubMed ID: 36459290
[TBL] [Abstract][Full Text] [Related]
13. Plasma mammaglobin messenger RNA in breast cancer patients as an addition to serum tumor.
El-Attar NI; Gaefar HA
Egypt J Immunol; 2007; 14(2):111-21. PubMed ID: 20306663
[TBL] [Abstract][Full Text] [Related]
14. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
[TBL] [Abstract][Full Text] [Related]
15. Serum microRNA-155 as a potential biomarker to track disease in breast cancer.
Sun Y; Wang M; Lin G; Sun S; Li X; Qi J; Li J
PLoS One; 2012; 7(10):e47003. PubMed ID: 23071695
[TBL] [Abstract][Full Text] [Related]
16. Serum MiRNA-27a as potential diagnostic nucleic marker for breast cancer.
Swellam M; Zahran RFK; Ghonem SA; Abdel-Malak C
Arch Physiol Biochem; 2021 Feb; 127(1):90-96. PubMed ID: 31145011
[TBL] [Abstract][Full Text] [Related]
17. Analysis of serum genome-wide microRNAs for breast cancer detection.
Wu Q; Wang C; Lu Z; Guo L; Ge Q
Clin Chim Acta; 2012 Jul; 413(13-14):1058-65. PubMed ID: 22387599
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic power of circulating micro ribonucleic acid 34a in combination with cancer antigen 15-3 as a potential biomarker of breast cancer.
Raheem AR; Abdul-Rasheed OF; Al-Naqqash MA
Saudi Med J; 2019 Dec; 40(12):1218-1226. PubMed ID: 31828273
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-29a upregulates MMP2 in oral squamous cell carcinoma to promote cancer invasion and anti-apoptosis.
Lu L; Xue X; Lan J; Gao Y; Xiong Z; Zhang H; Jiang W; Song W; Zhi Q
Biomed Pharmacother; 2014 Feb; 68(1):13-9. PubMed ID: 24210072
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs and metastasis-related gene expression in Egyptian breast cancer patients.
Hafez MM; Hassan ZK; Zekri AR; Gaber AA; Al Rejaie SS; Sayed-Ahmed MM; Al Shabanah O
Asian Pac J Cancer Prev; 2012; 13(2):591-8. PubMed ID: 22524830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]